Current evaluation and management of pheochromocytoma.
D000293:Adolescent; D000310:Adrenal Gland Neoplasms; D000328:Adult; D000792:Angiography; D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D002404:Catheterization; D004285:Dogs; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D010690:Phlebography; D011433:Propranolol / Q000627:therapeutic use; D011860:Radiography, Abdominal; D013565:Sympatholytics / Q000627:therapeutic use; D014567:Urography; D014680:Veins
D002395:Catecholamines; D013565:Sympatholytics; D010643:Phenoxybenzamine; D011433:Propranolol; D006854:Hydrocortisone; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine